Skip to main content
Loading

Understanding the Fundraising Environment for Biotech Companies

October 15, 2024
Venetian Room
The latest HSBC Venture Healthcare report shows increased levels of investment in 2024 with Seed and Series A total investment doubling and investment in preclinical deals already surpassing 2023. The HSBC Innovation team will provide a summary presentation on these promising signals followed by a panel discussion where investors and biotech executives will provide strategies for companies to access capital and continue advancing their therapies to the next phase of development. ​
Moderator
Jesse Essaff, Director, Life Science & Healthcare, Commercial Banking - HSBC Bank USA
Speakers
Srini Akkaraju - MD, PhD, Founder and Managing General Partner - Samsara BioCapital
Jonathan Norris, Managing Director - HSBC Innovation
Lori Hu, Managing Director - Vertex Ventures HC

DOUBLE HELIX SPONSOR

HELIX SPONSOR

PREMIER SPONSOR

CONFERENCE SPONSORS